Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-079897)

Filing Details

Accession Number:: 0001104659-15-079897
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-18 14:26:35
Reporting Period:: 2015-11-16

Filing Date:: 2015-11-18
Accepted Time:: 2015-11-18 14:26:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1640266	Voyager Therapeutics Inc.	VYGR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1121404	Sanofi	54 Rue La Boetie Paris 75008		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock Par Value Per Share $ 0.001	Acquisiton	2015-11-10	2,352,941	$0.00	2,352,941	No	4	C	Indirect	Via wholly owned subsidiary Aventis Inc.
Common Stock Par Value Per Share $ 0.001	Acquisiton	2015-11-16	125,000	$14.00	2,477,941	No	4	P	Indirect	Via wholly owned subsidiary Aventis Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Via wholly owned subsidiary Aventis Inc.
No	4	P	Indirect	Via wholly owned subsidiary Aventis Inc.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stocks	Shares of Series B convertible preferred stock	Disposition	2015-11-10	10,000,000	$0.00	2,352,941	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Conversion upon Initial Public Offering